{"id":9012,"date":"2022-07-19T12:58:01","date_gmt":"2022-07-19T12:58:01","guid":{"rendered":"https:\/\/ifpma.flywheelsites.com\/news\/berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics\/"},"modified":"2023-01-09T22:18:31","modified_gmt":"2023-01-09T22:18:31","slug":"berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics","status":"publish","type":"news","link":"https:\/\/www.ifpma.org\/news\/berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics\/","title":{"rendered":"Berlin Declaration: Biopharmaceutical Industry Vision for Equitable Access in Pandemics"},"content":{"rendered":"<p class=\"intro\">The innovative biopharmaceutical industry, having developed COVID-19 vaccines and treatments at record speed and in historic quantities, proposes to create a collaborative solution for more equitable rollout of vaccines, treatments and diagnostics for future pandemics.<\/p>\n<p>In particular, the innovative biopharmaceutical industry is willing to reserve an allocation of real-time production of vaccines, treatments and diagnostics for priority populations in lower income countries and take measures to make them available and affordable.<\/p>\n<blockquote><span class='bctt-click-to-tweet'><span class='bctt-ctt-text'><a href='https:\/\/twitter.com\/intent\/tweet?url=https%3A%2F%2Fwww.ifpma.org%2Fnews%2Fberlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics%2F&#038;text=We%20call%20on%20other%20stakeholders%20to%20work%20together%20with%20industry%20to%20shape%20a%20future%20where%20everyone%20is%20better%20protected%20from%20the%20threat%20of%20pandemics.&#038;related' target='_blank'rel=\"noopener noreferrer\">We call on other stakeholders to work together with industry to shape a future where everyone is better protected from the threat of pandemics. <\/a><\/span><a href='https:\/\/twitter.com\/intent\/tweet?url=https%3A%2F%2Fwww.ifpma.org%2Fnews%2Fberlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics%2F&#038;text=We%20call%20on%20other%20stakeholders%20to%20work%20together%20with%20industry%20to%20shape%20a%20future%20where%20everyone%20is%20better%20protected%20from%20the%20threat%20of%20pandemics.&#038;related' target='_blank' class='bctt-ctt-btn'rel=\"noopener noreferrer\">Tweet this<\/a><\/span><\/blockquote>\n<p>To be successful, we call on other stakeholders to work together with industry to help make this proposal a reality and shape a future where everyone is better protected from the threat of pandemics.<\/p>\n<p>This Berlin Declaration draws on the lessons we have learned and sets out an approach for more equitable pandemic preparedness and response, based on commitments and contributions from a global collaboration of public, private and charitable sectors together with civil society. Critical for success is to ensure that pandemic VTDs reach those who need them most, no matter where they live, from the outset of future pandemics.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The innovative biopharmaceutical industry, having developed COVID-19 vaccines and treatments at record speed and in historic quantities, proposes to create a collaborative solution for more equitable rollout of vaccines, treatments and diagnostics for future pandemics. In particular, the innovative biopharmaceutical industry is willing to reserve an allocation of real-time production of vaccines, treatments and diagnostics&#8230;<\/p>\n","protected":false},"featured_media":0,"template":"","news_type":[4],"topic":[21,22,19],"class_list":["post-9012","news","type-news","status-publish","hentry","news_type-statement","topic-covid-19","topic-pandemic-preparedness","topic-vaccines"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Berlin Declaration: Biopharmaceutical Industry Vision for Equitable Access in Pandemics | IFPMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ifpma.org\/news\/berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Berlin Declaration: Biopharmaceutical Industry Vision for Equitable Access in Pandemics | IFPMA\" \/>\n<meta property=\"og:description\" content=\"The innovative biopharmaceutical industry, having developed COVID-19 vaccines and treatments at record speed and in historic quantities, proposes to create a collaborative solution for more equitable rollout of vaccines, treatments and diagnostics for future pandemics. In particular, the innovative biopharmaceutical industry is willing to reserve an allocation of real-time production of vaccines, treatments and diagnostics...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ifpma.org\/news\/berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics\/\" \/>\n<meta property=\"og:site_name\" content=\"IFPMA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IFPMA\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-09T22:18:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-social-preview.png\" \/>\n\t<meta property=\"og:image:width\" content=\"801\" \/>\n\t<meta property=\"og:image:height\" content=\"801\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@IFPMA\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ifpma.org\/news\/berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics\/\",\"url\":\"https:\/\/www.ifpma.org\/news\/berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics\/\",\"name\":\"Berlin Declaration: Biopharmaceutical Industry Vision for Equitable Access in Pandemics | IFPMA\",\"isPartOf\":{\"@id\":\"https:\/\/www.ifpma.org\/#website\"},\"datePublished\":\"2022-07-19T12:58:01+00:00\",\"dateModified\":\"2023-01-09T22:18:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ifpma.org\/news\/berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ifpma.org\/news\/berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ifpma.org\/news\/berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ifpma.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\/\/www.ifpma.org\/news\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Berlin Declaration: Biopharmaceutical Industry Vision for Equitable Access in Pandemics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ifpma.org\/#website\",\"url\":\"https:\/\/www.ifpma.org\/\",\"name\":\"IFPMA\",\"description\":\"Innovating to improve health worldwide\",\"publisher\":{\"@id\":\"https:\/\/www.ifpma.org\/#organization\"},\"alternateName\":\"International Federation of Pharmaceutical Manufacturers and Associations\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ifpma.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ifpma.org\/#organization\",\"name\":\"IFPMA\",\"alternateName\":\"International Federation of Pharmaceutical Manufacturers and Associations\",\"url\":\"https:\/\/www.ifpma.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png\",\"contentUrl\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png\",\"width\":1379,\"height\":733,\"caption\":\"IFPMA\"},\"image\":{\"@id\":\"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/IFPMA\/\",\"https:\/\/x.com\/IFPMA\",\"https:\/\/www.linkedin.com\/company\/ifpma\/\",\"https:\/\/www.youtube.com\/user\/ifpma\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Berlin Declaration: Biopharmaceutical Industry Vision for Equitable Access in Pandemics | IFPMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ifpma.org\/news\/berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics\/","og_locale":"en_US","og_type":"article","og_title":"Berlin Declaration: Biopharmaceutical Industry Vision for Equitable Access in Pandemics | IFPMA","og_description":"The innovative biopharmaceutical industry, having developed COVID-19 vaccines and treatments at record speed and in historic quantities, proposes to create a collaborative solution for more equitable rollout of vaccines, treatments and diagnostics for future pandemics. In particular, the innovative biopharmaceutical industry is willing to reserve an allocation of real-time production of vaccines, treatments and diagnostics...","og_url":"https:\/\/www.ifpma.org\/news\/berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics\/","og_site_name":"IFPMA","article_publisher":"https:\/\/www.facebook.com\/IFPMA\/","article_modified_time":"2023-01-09T22:18:31+00:00","og_image":[{"width":801,"height":801,"url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-social-preview.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@IFPMA","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ifpma.org\/news\/berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics\/","url":"https:\/\/www.ifpma.org\/news\/berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics\/","name":"Berlin Declaration: Biopharmaceutical Industry Vision for Equitable Access in Pandemics | IFPMA","isPartOf":{"@id":"https:\/\/www.ifpma.org\/#website"},"datePublished":"2022-07-19T12:58:01+00:00","dateModified":"2023-01-09T22:18:31+00:00","breadcrumb":{"@id":"https:\/\/www.ifpma.org\/news\/berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ifpma.org\/news\/berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ifpma.org\/news\/berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ifpma.org\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.ifpma.org\/news\/"},{"@type":"ListItem","position":3,"name":"Berlin Declaration: Biopharmaceutical Industry Vision for Equitable Access in Pandemics"}]},{"@type":"WebSite","@id":"https:\/\/www.ifpma.org\/#website","url":"https:\/\/www.ifpma.org\/","name":"IFPMA","description":"Innovating to improve health worldwide","publisher":{"@id":"https:\/\/www.ifpma.org\/#organization"},"alternateName":"International Federation of Pharmaceutical Manufacturers and Associations","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ifpma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ifpma.org\/#organization","name":"IFPMA","alternateName":"International Federation of Pharmaceutical Manufacturers and Associations","url":"https:\/\/www.ifpma.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png","contentUrl":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png","width":1379,"height":733,"caption":"IFPMA"},"image":{"@id":"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IFPMA\/","https:\/\/x.com\/IFPMA","https:\/\/www.linkedin.com\/company\/ifpma\/","https:\/\/www.youtube.com\/user\/ifpma"]}]}},"_links":{"self":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/news\/9012","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/media?parent=9012"}],"wp:term":[{"taxonomy":"news_type","embeddable":true,"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/news_type?post=9012"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/topic?post=9012"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}